Antares Pharma, Inc. (ATRS)

[scubastevo80]

TD - I strongly agree. Many of us know that this is a pipeline play that has a robust pipeline of proprietary and partnered products now through 2017. 2015 Teva pen launches, 2016 QST, 2017 QSM. That's all in addition to the Otrexup sales that should gain traction this year. I'm holding all of my shares am not worried about the $2 price. Traders can trade it lower or higher, I'll be holding on for quite some time as I see a bright future for this company. I don't expect 300% returns in a year, but I think growth will ramp up aggressively in the coming 3 years.